14 December 2022
Money and Me: Growth opportunities in Ophthalmology investments
Did you know, it is predicted that myopia alone will impact nearly half the global population by 2050? With that in mind, Zhaoke Ophthalmology has developed a new innovative drug, NVK002, that seeks to address this concern.
Join in the conversation with Dan Koh and Zia-ul Raushan as they invite Lisa Feng, CFO, Zhaoke Ophthalmologyon today’s episode of Money and Me to talk about what her company is doing to position themselves as a market leader in this space and the opportunities presented to investors looking to dabble in the world of eye health.

Download this podcast.